Table 4.

Summary of the EORTC and PERCIST 1.0 criteria

	EORTC (79)	PERCIST 1.0 (80)
CMR	Complete resolution of FDG uptake in all lesions	Complete resolution of FDG uptake in all lesions
PMR	A > 25% reduction in the sum of SUVmax after more than one cycle of therapy	A ≥ 30% reduction in SULpeak and an absolute drop of 0.8 SULpeak units
SMD	Does not qualify for other categories	Does not qualify for other categories
PMD	A > 25% increase in the sum of SUVmax New FDG-avid lesions	A ≥ 30% increase in SULpeak and absolute increase of 0.8 SULpeak units New FDG-avid lesion

EORTC European organization for research and treatment of cancer, PERCIST PET response criteria in solid tumors, CMR complete metabolic response, PMR progressive metabolic disease, PMR partial metabolic response, SMD stable metabolic disease, FDG fluorodeoxyglucose, SUVmax maximum standardized uptake value, SULpeak peak lean body mass standardized uptake value